Total Payments
$10,127
2024 Payments
$1,561
Companies
51
Transactions
700
Medicare Patients
12,449
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$10,108 (99.8%)
Education$19.12 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,108 | 695 | 99.8% |
| Education | $19.12 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,209 | 74 | $0 (2024) |
| Novo Nordisk Inc | $1,141 | 97 | $0 (2024) |
| ABBVIE INC. | $646.20 | 42 | $0 (2024) |
| PFIZER INC. | $637.51 | 56 | $0 (2024) |
| Amgen Inc. | $616.78 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $616.15 | 54 | $0 (2021) |
| Merck Sharp & Dohme LLC | $515.94 | 40 | $0 (2024) |
| Lilly USA, LLC | $473.42 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $445.80 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $424.53 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,561 | 75 | AstraZeneca Pharmaceuticals LP ($232.02) |
| 2023 | $1,538 | 90 | AbbVie Inc. ($219.08) |
| 2022 | $1,204 | 82 | ABBVIE INC. ($185.59) |
| 2021 | $1,321 | 80 | Esperion Therapeutics, Inc. ($181.54) |
| 2020 | $568.01 | 37 | AstraZeneca Pharmaceuticals LP ($127.73) |
| 2019 | $1,127 | 87 | Novo Nordisk Inc ($160.47) |
| 2018 | $1,454 | 124 | Novo Nordisk Inc ($292.70) |
| 2017 | $1,354 | 125 | SANOFI-AVENTIS U.S. LLC ($258.64) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Oncology | ||||||
| 10/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: VACCINES | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Endocrinology | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $122.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,085 | 5,244 | $546,650 | $306,118 |
| 2022 | 29 | 3,201 | 5,782 | $580,520 | $316,661 |
| 2021 | 32 | 3,193 | 5,690 | $543,105 | $308,832 |
| 2020 | 32 | 2,970 | 5,748 | $524,875 | $288,581 |
Total Patients
12,449
Total Services
22,464
Medicare Billing
$1.2M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 368 | 766 | $118,730 | $62,452 | 52.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 257 | 933 | $83,970 | $56,218 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 325 | 744 | $85,560 | $40,238 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 330 | 330 | $57,750 | $40,064 | 69.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 175 | 199 | $35,820 | $18,523 | 51.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 237 | 269 | $29,590 | $16,359 | 55.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 102 | 109 | $27,250 | $13,885 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 160 | 160 | $15,600 | $11,739 | 75.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 49 | 58 | $18,850 | $11,547 | 61.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 41 | 41 | $10,250 | $5,363 | 52.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 145 | 146 | $5,090 | $4,277 | 84.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 145 | 146 | $3,650 | $2,986 | 81.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 23 | 23 | $4,600 | $2,903 | 63.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 119 | 305 | $9,150 | $2,838 | 31.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $4,400 | $2,465 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $3,240 | $2,332 | 72.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 16 | 29 | $3,625 | $1,692 | 46.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $2,750 | $1,478 | 53.8% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 15 | 15 | $3,000 | $1,441 | 48.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 151 | 166 | $1,660 | $1,370 | 82.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $1,435 | $1,204 | 83.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 27 | $2,700 | $1,061 | 39.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 115 | 125 | $9,375 | $1,003 | 10.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 123 | 315 | $3,150 | $988.68 | 31.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 98 | $2,450 | $944.29 | 38.5% |
About Dr. Michael Debs, MD
Dr. Michael Debs, MD is a Internal Medicine healthcare provider based in North Royalton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063486082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Debs, MD has received a total of $10,127 in payments from pharmaceutical and medical device companies, with $1,561 received in 2024. These payments were reported across 700 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($10,108).
As a Medicare-enrolled provider, Debs has provided services to 12,449 Medicare beneficiaries, totaling 22,464 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location North Royalton, OH
- Active Since 02/15/2006
- Last Updated 02/11/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063486082
Products in Payments
- FARXIGA (Drug) $738.58
- Ozempic (Drug) $602.26
- XARELTO (Drug) $347.24
- TOUJEO (Drug) $335.46
- ENTRESTO (Drug) $327.36
- JARDIANCE (Drug) $323.84
- ELIQUIS (Drug) $321.40
- JANUVIA (Drug) $264.84
- UBRELVY (Drug) $248.11
- NURTEC ODT (Drug) $226.87
- Victoza (Drug) $222.79
- REXULTI (Drug) $218.69
- Vascepa (Drug) $217.92
- Prolia (Biological) $186.80
- MOUNJARO (Drug) $185.59
- AIRSUPRA (Drug) $167.10
- VRAYLAR (Drug) $164.51
- Kerendia (Drug) $160.99
- KRYSTEXXA (Biological) $152.08
- BYSTOLIC (Drug) $143.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.